Precision Spine launched the Dakota ACDF™ Standalone System for the treatment of degenerative disc disease. Dakota ACDF features a titanium plate polyetheretherketone (PEEK) cage with cortical cancellous screws for maximum support and a generous cavity for autogenous bone graft to help facilitate fusion.
The Dakota ACDF System is indicated for use in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine (C2-T1) at one-or two-disc levels with DDD defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. The device is placed via an anterior approach at the C2 to T1 disc levels. Patients should have at least six weeks of non-operative treatment prior to treatment with an intervertebral fusion device such as the Dakota ACDF System.
“The Dakota ACDF System represents another example of how Precision Spine is making good on its commitment to develop surgeon-designed devices that embody the advanced features surgeons need to help improve OR efficiency and achieve positive patient outcomes,” said Chris DeNicola, Chief Operating Officer of Precision Spine.
Precision Spine launched the Dakota ACDF™ Standalone System for the treatment of degenerative disc disease. Dakota ACDF features a titanium plate polyetheretherketone (PEEK) cage with cortical cancellous screws for maximum support and a generous cavity for autogenous bone graft to help facilitate fusion.
The Dakota ACDF System is indicated...
Precision Spine launched the Dakota ACDF™ Standalone System for the treatment of degenerative disc disease. Dakota ACDF features a titanium plate polyetheretherketone (PEEK) cage with cortical cancellous screws for maximum support and a generous cavity for autogenous bone graft to help facilitate fusion.
The Dakota ACDF System is indicated for use in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine (C2-T1) at one-or two-disc levels with DDD defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. The device is placed via an anterior approach at the C2 to T1 disc levels. Patients should have at least six weeks of non-operative treatment prior to treatment with an intervertebral fusion device such as the Dakota ACDF System.
“The Dakota ACDF System represents another example of how Precision Spine is making good on its commitment to develop surgeon-designed devices that embody the advanced features surgeons need to help improve OR efficiency and achieve positive patient outcomes,” said Chris DeNicola, Chief Operating Officer of Precision Spine.
Copy to clipboard 
